October 13, 2024 DCVMN W๐ผ๐ฟ๐ธ๐ณ๐ผ๐ฟ๐ฐ๐ฒ C๐ฎ๐ฝ๐ฎ๐ฐ๐ถ๐๐ B๐๐ถ๐น๐ฑ๐ถ๐ป๐ด Workshop in Dubai WeConnectToProtect Workforce Training Workshop
September 23, 2024 Presenting DCVMN’s strategic focus for 2024-25 at theย 2024 UNICEF Vaccine Industry Consultation CEO DCVMN Advocacy UNICEF WeConnectToProtect
September 20, 2024 Exploring Key Strategies for Scaling Up MCM Manufacturing at the i-MCM-Net Partners Meeting CEO DCVMN Advocacy developingcountries
August 15, 2024 Panacea Biotec and ICMR initiate Phase III Clinical Trial of DengiAll clinicaltrials Dengue
August 1, 2024 DCVMN at the Global Pandemic Preparedness Summit 2024 CEO DCVMN Advocacy WeConnectToProtect
July 2, 2024 DCVMN CEO in the “2nd Edition of The Global Event on Harnessing Private Sector Engagement for Sustainable Vaccine and Pharmaceutical Manufacturing in Africa”ย Africa DCVMN Advocacy Vaccines & immunization WeConnectToProtect
June 28, 2024 Regulatory Working Group Workshop on Next-Generation Sequencing (NGS) technology DCVMN achievements DCVMN Working Groups Vaccines & immunization
June 25, 2024 DCVMN at the Global Forum for Vaccine Sovereignty and Innovation CEO DCVMN Advocacy Vaccines & immunization
June 2, 2024 DCVMN at the โAdvancing Biomanufacturing Workforce Training for Global Health Equityโ Advocacy Event CEO DCVMN Advocacy Workforce Training